Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Rigel Pharmaceuticals Inc., 3 years.
Rigel Pharmaceuticals Inc.
Director
NeoGenomics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +24,400 | — | — |
| May 15, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +5,750 | — | — |
| Jun 1, 2025 | NeoGenomics Inc. | Grant or award | +12,254 | — | — |
| May 23, 2025 | Rigel Pharmaceuticals Inc. | Grant or award | +2,500 | — | — |
| Aug 10, 2024 | NeoGenomics Inc. | Option exercise | +11,336 | — | — |
| May 25, 2024 | Rigel Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
| May 26, 2023 | Rigel Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.